An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma

An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma

Abstract Background While some lung adenocarcinoma (LUAD) patients benefit long-term from treatment with immune checkpoint inhibitors, the sad reality is that a considerable proportion of patients do not. The classification of the LUAD tumor microenvironment (TME) can be used to conceptually compreh...

Full description

Bibliographic Details
Main Authors: Yuxin Wu, Kexin Li, Shuang Liang, Xiaoying Lou, Yiling Li, Danfei Xu, Yue Wu, Yuan Wang, Wei Cui
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Respiratory Research
Subjects:
Lung adenocarcinoma
Immunogenic cell death
Damage-associated molecular patterns
Signature
Prognosis
Immunotherapy
Online Access:https://doi.org/10.1186/s12931-023-02443-0

Internet

https://doi.org/10.1186/s12931-023-02443-0

Similar Items